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Introduction: Merkel cell carcinoma (MCC) is a rare and highly aggressive malignancy of the skin which occurs mainly in old people and is very uncommon in young individuals. A new tumor virus belonging to the Polyomaviridae family; Merkel Cell Polyomavirus (MCPyV) has recently been identified in more than 80% of MCCs.
Case Presentation: We conducted a retrospective review on the archives of the Department of Pathology; Imam Khomeini Hospital Cancer Institute affiliated to Tehran University of Medical Sciences to confirm the MCC samples and we found medical records and samples of a young case with MCC who developed leg skin and scalp tumor six and seven years after bone marrow transplantation, respectively. We analyzed patient formalin-fixed paraffin-embedded samples for the presence of MCPyV DNA using polymerase chain reaction (PCR) method, and the PCR amplicons were subjected to DNA sequencing. Merkel Cell Polyomavirus DNA was detected in both tumors from patient and sequence analysis of the viral LT3 region showed a close homology to strains circulating worldwide.
Conclusions: The findings of this study are consistent with the hypothesis that local, systemic, or tumor-induced immunosuppression may allow the MCPyV to initiate skin aggressive cancer. It is necessary to maintain regular check over patients taking immunosuppressive medications for MCPyV infection. Since there is not any information about detection and molecular biology analysis of MCPyV among Iranian patients with MCC, this study provides more information about MCC and MCPyV in Iran.
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1. IntroductionMerkel cell carcinoma (MCC) is a rare and often malig-nant neuroendocrine cancer of the skin that usually re-ported in the elderly white people and only five percent of cases are younger than 50 years old at the time of diag-nosis (1). Significant clinical characteristics of MCC have been summarized in an acronym: AEIOU (asymptomatic/lack of tenderness, expanding rapidly, immune suppres-sion, older than 50 years, ultraviolet exposed/fair skin) (2). Recently, a new human tumor virus belonging to the Poly-
omaviridae family and as a cause of MCCs is discovered, this virus is known as Merkel Cell Polyomavirus (MCPyV) (3). 
Merkel Cell Polyomavirus is a widespread, harmless mem-ber of the human viral flora which can launch cancer if it acquires a set of mutations in a susceptible host (elderly, patients with hematological malignancies or immuno-suppression). Infection with MCPyV usually occurs early in childhood and is asymptomatic, after which virus localizes in the body. Under very specific conditions like loss of immune surveillance, virus genome may clonally integrated into the host's genome. The integrated viral genome frequent-
ly contains specific truncating mutations in viral tumor antigen (T antigen) that prevent virus replication within the cells and disturb cellular signaling pathways. When this occurs tumor formation takes place (2, 4). There are a large number of studies about MCPyV detection in pa-tients with MCC from United States, Europe, Australia, and South East Asia but little is known about the other re-gions, especially Middle East (5-10). We herein carried out a retrospective review from archives of the Department of Pathology, Imam Khomeini Hospital Cancer Institute to confirm MCC samples, and then we found medical records and samples of a young case with MCC. We per-formed a molecular biologic analysis on the case forma-lin-fixed paraffin-embedded samples and detected MCPyV sequences for the first time in an Iranian MCC patient.
2. Case PresentationAccording to Imam Khomeini Hospital medical records a 25-year-old man was admitted to the Imam Khomeini Hospital Cancer Institute in December 2008 for a rap-
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idly growing mass on his left leg that had appeared two months earlier. The patient underwent bone marrow transplantation due to Hodgkin's lymphoma in 2002. Upon physical examination a 5 × 3 cm, solitary, firm, shiny red-purple nodule was noted (unfortunately there was not any photo from lesion in his medical records). Examination of the inguinal region revealed superficial lymph nodes enlargement. The patient subjected to sur-gical mass excision and histopathological examination by routine hematoxylin-eosin staining mainly showed subcutaneous tissue which is focally infiltrated by neo-plastic cells composed of small round cells with scant eosinophilic cytoplasm, round hyperchromatic nuclei arranged individually and finely dispersed salt and pep-per nuclear chromatin (Figure 1 A). The immunohistochemical staining of the tumor cells showed the characteristic perinuclear dot-like patterns of cytokeratin 20 (CK20) and was negative for cytokera-tin-7 (CK7), leukocyte common antigen (LCA) and thyroid transcription factor 1 (TTF1) (Figure 1 B, negative results not shown). On the basis of immunohistochemical fea-tures, MCC diagnosis was established. In July 2009, eight months after the surgical removal of the leg skin tumor, patient complained of a solitary, 5 × 4 cm nodule on his scalp. The mass was removed by surgical operation and MCC was found in the resected specimen by either hema-toxylin-eosin stain or immunostaining for CK20. The pa-tient passes away eight month later. The Formalin-fixed paraffin-embedded tissue sections were investigated to determine if they harbored MCPyV DNA sequences or not. Tissue sections (10 µm thick) were deparaffinized with xylene and subjected to absolute ethanol to remove the xylene. Genomic DNA was then extracted using a QIAamp DNA Mini kit (Qiagen GmbH, Hilden, Germany) accord-ing to the manufacturer’s instructions. A 123-base pair (bp) segment of human β-globin gene was used as amplification control to ascertain the quality 
of the DNA, as described previously (11). For detection of 
MCPyV DNA, LT3 primer which is very specific for ampli-fication of the MCPyV T antigen (TAg) sequence was used (3). All primers were synthesized by Metabion Interna-tional AG (Martinsried, Germany). Merkel Cell Polyomavi-
rus DNA was detected in both tumors of patient (Figure 2 A) and 309 bp putative PCR product was cloned into the pTZ57R/T PCR cloning vector (InsTAclone™ PCR cloning Kit, Fermentas, MD, USA), then submitted for sequenc-ing (Bioneer, Daejeon, South Korea). The sequences were aligned with reference sequences of MCPyV (MCC350, MCC339, TKS, MKL-1) using the National Center for Bio-technology Information Blast algorithm. The sequences were deposited in GenBank with the Accession Numbers KF442250 and KF442251. The results of sequence align-ment showed that they were 100% identical to those of the MCC339 and MKL-1 isolates.
3. DiscussionIn 2008, DNA genome of a new tumor virus, MCPyV, dis-covered clonally integrated into the genomes of MCC pa-tients, indicating infection prior to clonal expansion of the tumor cells (3). Association between MCPyV and MCC has been supported by the other studies and it is the only member of the Polyomaviridae family convincingly linked to human cancer (5-8). Merkel Cell Polyomavirus turned out to be a ubiquitous virus among human populations and its seroprevalence ranges between 45-81% (12-14). Low amounts of viral DNA have been detected in the large spectrum of normal human tissues and in healthy skin flora (4). Under suitable conditions like ultraviolet light (UV) exposure, host immunosuppression and hemato-logical malignancies, this harmless virus can acquires signature mutations in the large T antigen (LTAg) coding portion of its genome, fortuitously integrates into the host genome and initiate tumorigenesis (15, 16).
Figure 1. Merkel Cell Carcinoma
A, Small round cells with hyperchromatic nuclei and scant cytoplasm in dermis with invasion into lymphatic vessels (H&E staining, original magnifica-tion × 20); B, Immunoreaction with CK20 shows perinuclear dots (CK20, original magnification × 40).
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Figure 2. Merkel Cell Polyomavirus DNA Detection in an Iranian Patient With Merkel Cell Carcinoma
The PCR products amplified with the LT3 primers and analyzed on 2.0% agarose gel electrophoresis. A, Lane M: 100-bp DNA marker; Lane N: Nega-tive control, Lane 008: PCR product (309 bp) of patient leg skin tumor in 2008, Lane 009: PCR product (309bp) of patient scalp tumor in 2009. B, Result of beta-globin housekeeping gene PCR assay to monitor DNA ex-traction efficiency, Lane M: 100-bp DNA size marker; Lane 009: PCR prod-uct (123 bp) of patient scalp tumor in 2009, Lane 008: PCR product (123 bp) of patient leg skin tumor in 2008.
Patients undergoing bone marrow transplantation are much more liable to develop malignancy. Immuno-suppressive therapy, body irradiation and treatment for graft-versus-host disease (GVHD) may act on the ability of the immune surveillance system against cancerous cells and invading pathogens like human tumor viruses. MCC 
arises much more often among organ transplant and pa-tients with AIDS (2). In the present study, we report the first case of MCPyV infection in an Iranian patient with MCC and to our knowledge, no previous reports have been published before in our country. This was the first 
MCPyV isolate from Iran and according to the nucleotide sequence of LT3 fragment it is very similar to the viruses originated from United States and Europe. We presented here a case of MCC in a young patient underwent bone marrow transplantation, which is a very rare case. Microscopically tumor sections showed a histopatho-logic and immunohistochemical staining pattern com-patible with MCC consists of small basophilic cells with scant cytoplasm and oval, medium-size nuclei. Immu-nohistochemically perinuclear CK20 positivity and TTF-1 negativity distinguish MCCs efficiently from other small cell carcinomas (17). It is notable to indicate there was a slight possibility that the tumor may cause a new pri-mary infection in the scalp rather than a metastasis from the earlier leg skin tumor. This possibility ruled out by 100% sequence identity in LT3 fragment between leg skin and scalp tumor viruses. In conclusion our report pres-ents MCPyV detection in a young patient underwent bone marrow transplantation with MCC in Iran for the first time and further studies are required to establish the prevalence of MCPyV in Iranian MCC patients.
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